News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Balance sheet
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
IDEAYA Biosciences (NASDAQ:IDYA) has received an average rating of "Moderate Buy" from sixteen brokerages, with an average 12-month price target of $50.13, significantly above its current share price of $36.30. The company's recent quarterly results showed revenue exceeding expectations but missed on earnings per …
Wall Street Zen downgraded IDEAYA Biosciences (NASDAQ:IDYA) from "hold" to "sell," despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $50.12. The company's shares opened at $36.30, and it recently reported a quarterly loss of $1.22 per share, …
Baker Bros. Advisors and its related entities have disclosed a 5.2% beneficial ownership stake in IDEAYA Biosciences, Inc. (IDYA), totaling 5,010,030 shares based on 96,375,637 shares outstanding as of June 30, 2026. The firm also holds prefunded warrants with a low exercise price but …
Ideal Power CEO David Somo discussed the company's Q2 2026 results, highlighting advancements in commercializing its B-TRAN® solid-state power technology for AI data centers and electric vehicle applications. The company made progress on its low-current solid-state circuit breaker project, shipped next-generation B-TRAN® samples to …
Laurence W. Lytton has disclosed a 7.5% beneficial ownership stake in Ideal Power Inc. (IPWR), according to a recent SEC filing (SCHEDULE 13G/A). This ownership comprises 959,856 shares of common stock and warrants, with 328,524 shares having sole voting and dispositive power, and warrants …
Ideal Power Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
Ideal Power Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
Ideal Power Inc. (NASDAQ:IPWR) is making significant strides in commercializing its B-TRAN semiconductor switch technology, including finalizing solid-state circuit breaker prototypes for a lead Asian customer for 800V AI data center and energy grid applications. The company also signed a long-term supply agreement with …
Ideal Power Inc. made significant progress in Q2 with its B-TRAN semiconductor switch technology, securing a long-term supply deal with an Asian wafer foundry and advancing customer projects for Nvidia's data centers and Stellantis' EV applications. Despite a net loss, the company successfully raised …
Ideal Power Inc. (Nasdaq: IPWR) announced its second-quarter 2026 financial results, highlighting progress in its B-TRAN® semiconductor technology commercialization. Key achievements include advancing projects with an Asian customer and Stellantis, securing a long-term wafer foundry agreement, and developing solutions for NVIDIA's 800V DC AI …
Ideal Power (IPWR) reported its Q2 2026 financial results, with revenues of $5,800 and a net loss of $3.4 million for the quarter, and a six-month net loss of $7.0 million. The company's cash and cash equivalents increased to $41.3 million due to net …
Ideal Power Inc. (IPWR) reported a second-quarter loss of $3.4 million, or 20 cents per share. The power conversion technologies developer posted revenue of $6,000 for the period. This financial summary was generated using data from Zacks Investment Research.
IDEAYA Biosciences (IDYA) reported a short interest of 10.11 million shares as of July 31, 2026, marking a 5.64% increase from the previous period. This represents 12.08% of the public float and a short interest ratio of 13.2 days to cover. The article provides …
Ideal Power Inc is projected to report a loss of 29 cents per share. This information comes from an earnings preview, indicating financial analysts' expectations for the company's upcoming performance. The full article is available through TradingView with a subscription.
This article from Stock Traders Daily discusses how Ideaya Biosciences Inc. (NASDAQ: IDYA) movements inform risk allocation models. It highlights key findings such as a strong near-term sentiment possibly leading to a long-term positive bias, and an exceptional 49.4:1 risk-reward setup. The analysis provides …
Search by ticker symbol or company name and select a result to open its chart.